| 000 | 01664 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515202232.0 | ||
| 264 | 0 | _c20100311 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1879-1891 | ||
| 024 | 7 |
_a10.1016/j.ajo.2009.09.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYamashita, Ayana | |
| 245 | 0 | 0 |
_aOne-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy. _h[electronic resource] |
| 260 |
_bAmerican journal of ophthalmology _cMar 2010 |
||
| 300 |
_a465-71.e1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aChoroid _xblood supply |
| 650 | 0 | 4 |
_aChoroid Diseases _xdrug therapy |
| 650 | 0 | 4 | _aColoring Agents |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndocyanine Green |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeripheral Vascular Diseases _xdiagnosis |
| 650 | 0 | 4 | _aPhotochemotherapy |
| 650 | 0 | 4 |
_aPhotosensitizing Agents _xadverse effects |
| 650 | 0 | 4 |
_aPorphyrins _xadverse effects |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 | _aVerteporfin |
| 650 | 0 | 4 |
_aVisual Acuity _xphysiology |
| 700 | 1 | _aShiraga, Fumio | |
| 700 | 1 | _aShiragami, Chieko | |
| 700 | 1 | _aOno, Aoi | |
| 700 | 1 | _aTenkumo, Kaori | |
| 773 | 0 |
_tAmerican journal of ophthalmology _gvol. 149 _gno. 3 _gp. 465-71.e1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ajo.2009.09.020 _zAvailable from publisher's website |
| 999 |
_c19421902 _d19421902 |
||